Tomorrow is Bone Density test day. NSL (Derbyshire Patient Transport) have been booked to pick me up any time after 8.30am but must get me to hospital before 10am. That’s what time I told them my appointment was - it isn’t, it’s at 10.30am! But don’t trust them to get me there on time if I told them the truth. They are supposed to be picking me up at around 1pm to bring me home. I won’t hold my breath!! 
Chris, have you been peeping through my keyhole to know I pick my nose??? No comment,
but thanks for the big hug. Sending one back as we all need them from time to time.
Dyane, did the baby shampoo help? Do you look like Rapunzel yet? If so, I want a refund as my baby shampoo hasn’t made a blind bit of difference yet!!
Poor Sandra, we all really feel for you and worry about you. Our little mother hen who needs a bit of mothering herself.
Sending you big hugs too.
Alison, we all seem to be getting strange aches and pains now. We can’t even blame it on chemo any more. Hope you get that sorted as well as your poor bum.
Linda, my chest pain seems to have gone too. I don’t know which muscle it was but it was right above the mx scar, which is why it worried me.
Hopefully, when the results from tomorrow’s test filter through to my onco, she will write to my GP about hormone tablets. I’m not seeing her again until 16th July so hope she gets them sorted before then 
Anyone ever heard of this drug?
"Raloxifene (marketed as Evista by Eli Lilly and Company) is an oral selective estrogen receptor modulator (SERM) that has estrogenic actions on bone and anti-estrogenic actions on the uterus and breast. It is used in the prevention of osteoporosis in postmenopausal women.
_ In 2006, the National Cancer Institute announced that raloxifene was as effective as tamoxifen in reducing the incidence of breast cancer in postmenopausal women at increased risk. A major adverse effect of tamoxifen is uterine cancer; raloxifene had fewer uterine cancers. Tamoxifen increased the risk of cataracts, but raloxifene did not. Both groups had more blood clots in veins and the lungs, but that side effect was more common with tamoxifen than raloxifene. On September 14, 2007, the U.S. Food and Drug Administration announced approval of raloxifene for reducing the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast cancer." _
I’ve never heard of it before, I don’t know if it is used over here, or just in the US.